AC
AGN

Alexandria Capital’s Allergan plc AGN Stock Holding History

Alexandria Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,290
Closed -$626K – 267
2018
Q3 		$626K Sell
3,290
-50
-1% -$9.19K 0.09% 160
2018
Q2 		$557K Sell
3,340
-1,378
-29% -$221K 0.08% 166
2018
Q1 		$794K Sell
4,718
-176
-4% -$29.5K 0.12% 144
2017
Q4 		$800K Buy
4,894
+4,886
+61,075% +$877K 0.12% 147
2017
Q3 		$2K Hold
8
– – ﹤0.01% 515
2017
Q2 		$2K Hold
8
– – ﹤0.01% 569
2017
Q1 		$2K Buy
8
+2
+33% +$466 ﹤0.01% 565
2016
Q4 		$1K Sell
6
-17
-74% -$3.52K ﹤0.01% 578
2016
Q3 		$5K Buy
23
+17
+283% +$4.15K ﹤0.01% 501
2016
Q2 		$1K Sell
6
-80
-93% -$18.4K ﹤0.01% 584
2016
Q1 		$23K Hold
86
– – ﹤0.01% 335
2015
Q4 		$27K Sell
86
-14
-14% -$4.17K 0.01% 329
2015
Q3 		$27K Buy
100
+5
+5% +$1.54K 0.01% 296
2015
Q2 		$29K Sell
95
-46
-33% -$13.7K 0.01% 306
2015
Q1 		$42K Buy
+141
New +$40.2K 0.02% 221

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Alexandria Capital's AGN Position: Q4 2018 in Review

Alexandria Capital sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 3,290 shares — an estimated $626K sold.

Alexandria Capital first reported a position in AGN in Q1 2015 and held it in 15 quarters. The position peaked at $800K in Q4 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Alexandria Capital reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Alexandria Capital sold 3,290 Allergan plc shares in Q4 2018, an estimated $626K.
  • Alexandria Capital first reported a position in Allergan plc in Q1 2015 and held it in 15 quarters.
  • Alexandria Capital's Allergan plc position peaked at $800K in Q4 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Alexandria Capital's 13F filing for Q4 2018, filed 14 Feb 2019.